Browse wide-ranging research at the frontiers of neuroscience supported by Wu Tsai Neurosciences Institute grants, awards, and training fellowships.
Projects
Wu Tsai Neurosciences Institute
SIGF - Graduate Fellowship
2022
Optimizing computational modeling of traumatic brain injury with machine learning: biomechanics and beyond
Traumatic brain injury (TBI) has become a global health hazard. If undetected, the brain damage of TBI can accumulate, calling for better TBI modeling and warning systems. TBI modeling involves three stages: head impact kinematics, brain deformation, and injuries.
Wu Tsai Neurosciences Institute
SIGF - Graduate Fellowship
2022
Mechanistic insights into glycerophospholipid metabolism in the lysosome
Phospholipid dysregulation is implicated in the pathogenesis of lysosomal storage disorders (LSDs). We found that glycerophosphodiesters (GPDs) accumulate in lysosomes derived from Batten disease models, a life-limiting LSD whose pathological mechanism remains elusive. GPDs are the degradation products of glycerophospholipid catabolism by phospholipases.
Knight Initiative for Brain Resilience
Innovation Award
2022
Manipulating inflammation in the aging brain to promote brain resilience
Inflammation is a hallmark of brain aging, yet the source of inflammation in the old brain — and how to eliminate it — is unknown. This team aims to provide insight on how inflammation affects the aging brain that could potentially lead to the generation of new therapies to promote brain resilience.
Knight Initiative for Brain Resilience
Innovation Award
2022
Mechanistic dissection and therapeutic capture of an exercise-inducible metabolite signaling pathway for brain resilience
Exercise improves cognition and protects against age-associated neurodegenerative diseases, but further research is needed to understand exactly how this occurs. This project aims to pave the way for therapeutics that can capture the benefits of exercise for promoting brain resilience.
Knight Initiative for Brain Resilience
Innovation Award
2022
Mutant microglia and resilience to Alzheimer’s disease
This project aims to identify how mutant peripheral immune cells that invade the brain might actually reduce Alzheimer’s disease risk. The research will explore how to mimic these cells’ resilience-promoting effects to design new Alzheimer’s therapies.
Knight Initiative for Brain Resilience
Innovation Award
2022
From gut to brain: reprogramming peripheral macrophages at the intestinal barrier to prevent age-associated inflammation and cognitive decline
This team will investigate whether a decline in intestinal immune cell metabolism drives age-related inflammation and cognitive decline. By replacing aged intestinal macrophages with metabolically healthy ones, they hope to develop a novel approach to enhance cognitive resilience.
Knight Initiative for Brain Resilience
Innovation Award
2022
Unleashing engineered T cells as disease sensors and therapeutic actuators for neurodegenerative disease
This project will explore whether amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) result from immune cells attacking altered neurons. The team aims to pioneer the use of engineered immune cells as therapies for neurodegenerative disorders.
Knight Initiative for Brain Resilience
Innovation Award
2022
Role of proteostasis and organelle homeostasis in brain resilience during aging
This team aims to define how and why protein production breaks down in aging cells, leading to disease. This research may lead to new diagnostic and therapeutic approaches against neurodegenerative diseases and potentially aging itself.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Predicting and promoting resilient brain aging trajectories
Using new animal models such as the African killifish, this team aims to develop approaches to predict individual brain aging trajectories early in life based on behaviors that can be modulated to promote healthy memory, executive function and processing speed as well as counter dementia.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Resilience to Synaptic Impairments in Neurodegenerative Disorders
This team will explore the idea that neurotoxic protein aggregates seen in neurodegenerative disorders act at the synaptic connections between cells, and that resilience against these disorders may come from natural synapse-supporting factors that could be transformed into new forms of therapy.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Preserving motor engrams in Parkinson's disease: Neural circuit and transcriptomic studies and strategies for resilient motor control
This team aims to better understand how Parkinson's disease attacks the brain's basic motor programs and to spawn novel therapies against the disease using gene-editing technology.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Mitochondrial DNA and Brain Resilience
This team proposes the first comprehensive study of how mitochondrial DNA is related to cognitive function and susceptibility to dementia in a diverse population of over 11,000 adults. The outcomes of this study will provide insight into possible racial disparities in brain health.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Sleep circuits in neurodegenerative disease and aging
This team plans to study whether changes in neurons in the midbrain that regulate sleep, wakefulness, and immunity could contribute to aging and neurodegeneration. If successful, this information could rescue deficits in sleep and restore a normal immune profile.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Defining the Subcellular Biology of Brain Aging and Neurodegeneration
This team plans to map how age-related dysfunction of cellular waste disposal in lysosomes could lead to neurodegenerative diseases, potentially laying the foundation for a map of organelle function in the brain.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Unlocking brain resilience with HDAC inhibition
This team aims to define a network of genes that contribute to stress resistance in neurons and identify how it could be activated to enhance brain resilience and protect against neurodegenerative disease.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Endocannabinoid metabolism as a driver of brain aging
This team aims to discover whether the brain’s endocannabinoid system is dysregulated during aging, triggering inflammation via molecules called prostaglandins. If so, a drug that decouples these systems might restore a youthful brain state and rescue cognitive function.
Knight Initiative for Brain Resilience
Catalyst Award
2022
Characterizing the Genetic Architecture of Neuropathology with Machine Learning
This team will study the brains of individuals who lived past ninety with their cognitive function intact, using advanced tissue imaging and computer science to understand mechanisms of resilience that could slow neurodegeneration and preserve brain health.